BANGKOK HOSPITAL INVESTS IN A MULTI-MILLION BAHT CORE LABORATORY

ข่าวทั่วไป Thursday May 10, 2001 14:58 —PRESS RELEASE LOCAL

Bangkok--May 10--Breakthrough PR
To Boost Competitiveness and Quality of Healthcare Services
Bangkok Hospital is investing 100 million Baht for the establishment of a core laboratory which is aimed at enhancing competitiveness and quality of healthcare services provided by all hospitals of the BGH Group throughout Thailand as well as its associate hospitals.
According to Dr. Pongsak Viddayakorn, M.D., Managing Director of Bangkok Hospital, the pooling of all resources of hospitals of the three groups, BGH, Ramkamhaeng and Samitivej, is a major strategic development that would significantly improve efficiency and quality, contributing to a healthy performance of all in the long run.
"The healthcare industry, particularly private hospitals, is increasingly under pressure to stay competitive. Maintaining the same high quality of service with the same incurred costs becomes much more demanding, especially with what hospitals must bear for diagnostic tests and many other types of medical examination needed to provide treatment for patients effectively and expediently," says Dr. Pongsak.
He notes that the core laboratory concept is not designed to compete with existing private commercial laboratories, but tailored essentially to streamline all administrative and operational aspects of diagnostic and therapeutic tests undertaken by the hospitals. "With the core laboratory, we will be able to achieve economies of scale that will contribute to much lower costs in diagnostics as well as greater cost efficiency in numerous areas, and be able to improve on the quality of diagnostics as well. So hospitals will benefit in terms of cost and treatment for patients from a more cost efficient management of resources."
To be set up in a central location of Bangkok, the core laboratory is scheduled to commence operation within 2001, and be fully operational within the first quarter of 2002. The laboratory is also projected to achieve a turnover of 500 million Baht by the year 2004.
Medca Japan Co., Ltd. (MCJ), an internationally renowned healthcare group formerly known as Kanto Biomedical Laboratory Co., Ltd., has been appointed as a non-equity partner providing comprehensive consultancy for the establishment of the core laboratory.
Medca Japan has been a longstanding partner of Bangkok Hospital in the development of various innovative healthcare services. In Japan, MJC also operates several laboratories, similar to the one planned by BGH, with a proven track record in the management of cost-efficient healthcare services.
News released for Bangkok Hospital by Breakthrough PR
For further information, please contact:
Khun Thanittha Laowakul Bangkok Hospital Tel. 310-3000
Khun Sitikorn Sangiumprong Breakthrough PR Tel. 719-6446-8 End.
-AN-

แท็ก bangkok hospital   thailand   Bangkok   central   nation   Japan  

เว็บไซต์นี้มีการใช้งานคุกกี้ ศึกษารายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว และ ข้อตกลงการใช้บริการ รับทราบ